Tele: 561.316.3330
Breaking Medical Device News

Tuesday, October 19, 2021
HomeHEALTHBioheart Personal Heart Monitor-Provides Information on User's Heart Performance

Bioheart Personal Heart Monitor-Provides Information on User’s Heart Performance

Bioheart, a personal heart monitor by Biotricity, Inc. is designed for individuals diagnosed with or at risk for cardiovascular disease.

Bioheart continuously monitors daily activities, and provides critical information on the user’s heart performance, empowering patients to understand better and manage their heart conditions.

Bioheart availability is targeted for Q3 2021. Biotricity will showcase Bioheart at Pepcom’s Digital Experience during CES 2021 on January 11, 2021. For an advance look at Bioheart, watch this video.

Bioheart is a natural extension to Biotricity’s cardiac diagnostic offering. Today, there is no solution for personal lifestyle management in cardiac diagnostics. Bioheart will fill this gap while enhancing awareness for patients so they can visit their physician and receive a proper diagnosis.

“Cardiovascular disease is the number one killer in the US. Millions of cardiac patients are living with cardiac disease with no insight into their condition,” said Dr. Waqaas Al-Siddiq, founder & CEO, Biotricity Inc. “Bioheart will help cardiac patients to take control of their condition and improve their quality of life.”

Key features of Bioheart include:

  • Dry Lead Technology – Bioheart is one of the only wearable devices that continuously collects ECG (heart) data through dry lead electrodes.
  • Provides Critical Information – Bioheart monitors heart health, respiration, physical activity, and calorie burn in a user-friendly format.
  • Ergonomic Design – Bioheart is designed to maximize patient comfort during regular day-to-day activities through its adjustable chest band.
  • Three-Channel Recording – Bioheart is one of the only consumer wearable that can provide continuous three-channel recording of ECG data. All other known consumer devices are one-channel and lack continuous recording capability.
  • Extended Battery Life – The device can be worn continuously for 48 hours before requiring a one-hour charge, enabling long term continuous data collection.
  • Complementing Data – Individuals can gain further insights by sharing their Bioheart data with health care professionals for lifestyle management.
  • Proven Technology – Bioheart uses the same core ECG technology used in the FDA-cleared Bioflux to diagnose patients.

“We are very excited about the addition of the Bioheart personal heart monitor to our product portfolio and believe it will complement our existing and future product offerings.”, added Dr. Waqaas Al Siddiq. FAQ can be found here.

Medical Device News Magazine
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected


Don't Miss

Adam S. Epstein New CEO of AliMed, Inc.

In his prior role as Chief Commercial Officer, Epstein directed all customer-facing, demand generation and product development activities. Under his new leadership, AliMed will continue to build a robust portfolio of contracted positions with major, national GPO’s, IDN’s, and Distribution partners to drive sales growth.

Tony Collins Appointed CFO of Xenter

“Xenter is building a platform for medical innovations that is transformational. The only way we can achieve our objectives is if we have great leaders like Tony Collins leading our company,” stated Richard J. Linder, Founder, Chairman & CEO of Xenter, Inc. “Tony brings incredible depth and experience to his new role as Chief Financial Officer.

HistoSonics Receives FDA “Breakthrough Device Designation” for Novel Sonic Beam Therapy

Histotripsy of the liver provides clinicians the first automated external beam therapy using acoustic energy to mechanically destroy and liquefy tissue in the liver without incisions, ionizing radiation or heat.

Scott Sexton Appointed President at FIGUR8

"Scott brings to FIGUR8 30 years of workers' compensation, casualty, disability, and commercial health experience, most recently serving as a market leader for CorVel's national carrier practice sales team," said Nan-Wei Gong, CEO, and co-founder of FIGUR8.

Endolumik Inc. of Morgantown Secures $175,000 Angel Investment from Country Roads Angel Network

Endolumik, Inc. was founded in May 2020 by Mara McFadden, chief executive officer, and Dr. Nova Szoka, inventor of the surgical device.

Insulet Announces Board of Director Changes with Appointment of Luciana Borio, M.D. and Retirement of Sally W. Crawford

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced...

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

By using this website you agree to accept Medical Device News Magazine Privacy Policy